Search research articles
Contact Us
Filters
Showing results (941-950 of 991) with videos related to
Page
of 100
Sort By:
Antimicrobial Agents and Chemotherapy
|
July 31, 2013
A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ
Hilde M van der Schaar, Pieter Leyssen, Hendrik J Thibaut, et al.
BMC Genomics
|
July 6, 2018
Genome variants associated with RNA splicing variations in bovine are extensively shared between tissues
Ruidong Xiang, Ben J Hayes, Christy J Vander Jagt, et al.
Molecular Metabolism
|
August 28, 2018
Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes
Ali J Chakera, Paul S Hurst, Gill Spyer, et al.
Journal of Medicinal Chemistry
|
April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers
Francine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Scientific Reports
|
April 6, 2023
Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C disease
Sarah Kim, Kathleen Ochoa, Sierra E Melli, et al.
Scandinavian Journal of Pain
|
June 19, 2018
Experimental design and reporting standards for improving the internal validity of pre-clinical studies in the field of pain: Consensus of the IMI-Europain consortium
K L Knopp, C Stenfors, C Baastrup, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1
Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Journal of Medicinal Chemistry
|
June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site
Leslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Journal of Medicinal Chemistry
|
June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles
M B van Niel, I Collins, M S Beer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 2, 2023
SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases
Mark A Colijn, Prescilla Carrion, Guillaume Poirier-Morency, et al.
Page
of 100
Search research articles
Search
Showing results (941-950 of 991) with videos related to
Sort By:
Page
of 100
Antimicrobial Agents and Chemotherapy
|
July 31, 2013
A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβ
Hilde M van der Schaar, Pieter Leyssen, Hendrik J Thibaut, et al.
BMC Genomics
|
July 6, 2018
Genome variants associated with RNA splicing variations in bovine are extensively shared between tissues
Ruidong Xiang, Ben J Hayes, Christy J Vander Jagt, et al.
Molecular Metabolism
|
August 28, 2018
Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes
Ali J Chakera, Paul S Hurst, Gill Spyer, et al.
Journal of Medicinal Chemistry
|
April 16, 2004
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers
Francine Sternfeld, Robert W Carling, Richard A Jelley, et al.
Scientific Reports
|
April 6, 2023
Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C disease
Sarah Kim, Kathleen Ochoa, Sierra E Melli, et al.
Scandinavian Journal of Pain
|
June 19, 2018
Experimental design and reporting standards for improving the internal validity of pre-clinical studies in the field of pain: Consensus of the IMI-Europain consortium
K L Knopp, C Stenfors, C Baastrup, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1
Wesley P Blackaby, Richard T Lewis, Joanne L Thomson, et al.
Journal of Medicinal Chemistry
|
June 25, 2004
Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site
Leslie J Street, Francine Sternfeld, Richard A Jelley, et al.
Journal of Medicinal Chemistry
|
June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles
M B van Niel, I Collins, M S Beer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 2, 2023
SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases
Mark A Colijn, Prescilla Carrion, Guillaume Poirier-Morency, et al.
Page
of 100